|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
La Jolla Pharmaceutical Co (LJPC) |
|
|
$6.22 0.00 (0.00%) as of 4:30 Thu 8/18
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
27,470,000 |
| Market
Cap: |
170.86(M) |
| Last
Volume: |
2,592,323 |
Avg
Vol: |
2,585,188 |
| 52
Week Range: |
$6.22 - $6.22 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mulroy Dennis |
Chief Financial Officer |
• – – |
2018-12-14 |
4 |
A |
$10.88 |
$305 |
D/D |
28 |
622 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2018-12-14 |
4 |
A |
$10.88 |
$1,219 |
D/D |
112 |
1,281,172 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2018-12-14 |
4 |
A |
$10.88 |
$185 |
D/D |
17 |
2,164 |
|
- |
|
| Carver Jennifer |
Chief Operating Officer |
• – – |
2018-12-14 |
4 |
A |
$10.88 |
$1,175 |
D/D |
108 |
6,968 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2018-12-14 |
4 |
A |
$10.88 |
$762 |
D/D |
70 |
74,633 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2018-11-30 |
4 |
A |
$12.30 |
$320 |
D/D |
26 |
594 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
A |
$12.30 |
$775 |
D/D |
63 |
74,563 |
|
- |
|
| Carver Jennifer |
Chief Operating Officer |
• – – |
2018-11-30 |
4 |
A |
$12.30 |
$1,181 |
D/D |
96 |
6,860 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2018-11-30 |
4 |
A |
$12.30 |
$1,230 |
D/D |
100 |
1,281,060 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2018-11-30 |
4 |
A |
$12.30 |
$197 |
D/D |
16 |
2,147 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2018-11-15 |
4 |
A |
$12.67 |
$304 |
D/D |
24 |
568 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2018-11-15 |
4 |
A |
$12.67 |
$203 |
D/D |
16 |
2,131 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2018-11-15 |
4 |
A |
$12.67 |
$1,229 |
D/D |
97 |
1,280,960 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2018-11-15 |
4 |
A |
$12.67 |
$773 |
D/D |
61 |
74,500 |
|
- |
|
| Carver Jennifer |
Chief Operating Officer |
• – – |
2018-11-15 |
4 |
A |
$12.67 |
$1,191 |
D/D |
94 |
6,764 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2018-10-31 |
4 |
A |
$13.86 |
$776 |
D/D |
56 |
74,439 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2018-10-31 |
4 |
A |
$13.86 |
$208 |
D/D |
15 |
2,115 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2018-10-31 |
4 |
A |
$13.86 |
$305 |
D/D |
22 |
544 |
|
- |
|
| Carver Jennifer |
Chief Operating Officer |
• – – |
2018-10-31 |
4 |
A |
$13.86 |
$1,178 |
D/D |
85 |
6,670 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2018-10-31 |
4 |
A |
$13.86 |
$1,233 |
D/D |
89 |
1,280,863 |
|
- |
|
| Rolke James |
Chief Scientific Officer |
• – – |
2018-10-15 |
4 |
A |
$13.81 |
$760 |
D/D |
55 |
74,383 |
|
- |
|
| Carver Jennifer |
Chief Operating Officer |
• – – |
2018-10-15 |
4 |
A |
$13.81 |
$1,174 |
D/D |
85 |
6,585 |
|
- |
|
| Chawla Lakhmir S |
Chief Medical Officer |
• – – |
2018-10-15 |
4 |
A |
$13.81 |
$207 |
D/D |
15 |
2,100 |
|
- |
|
| Tidmarsh George F |
President, CEO & Secretary |
• • – |
2018-10-15 |
4 |
A |
$13.81 |
$1,215 |
D/D |
88 |
1,280,774 |
|
- |
|
| Mulroy Dennis |
Chief Financial Officer |
• – – |
2018-10-15 |
4 |
A |
$13.81 |
$304 |
D/D |
22 |
522 |
|
- |
|
333 Records found
|
|
Page 11 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
